Impact of MammaPrint and BluePrint on early breast cancer treatment decisions: WSG PRIMe study results

被引:0
|
作者
Wuerstlein, R. [1 ]
Grischke, E. M. [2 ]
Gluz, O. [3 ]
Kates, R. [3 ]
Persoon, M. [4 ]
Thill, M. [5 ]
Hasmueller, S. [6 ]
Knauer, M. [7 ]
Pusch, R. [8 ]
Harbeck, N. [1 ,3 ]
机构
[1] Univ Munich, Breast Ctr, Munich, Germany
[2] Univ Tubingen Hosp, Breast Canc Ctr, Tubingen, Germany
[3] WSG, Monchengladbach, Germany
[4] Agendia, Amsterdam, Netherlands
[5] Agaples Markus Hosp, Frankfurt, Germany
[6] Ebersberg Clin, Ebersberg, Germany
[7] Kantonsspital St Gallen, Breast Ctr, St Gallen, Switzerland
[8] Int Med IV Clin Wels Grieskirchen, Wels Grieskirchen, Austria
来源
BREAST | 2017年 / 32卷
关键词
D O I
10.1016/S0960-9776(17)30341-7
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P255
引用
收藏
页码:S107 / S107
页数:1
相关论文
共 50 条
  • [41] 5-year outcomes in the NBRST trial: Preoperative MammaPrint and BluePrint breast cancer subtype is associated with neoadjuvant treatment response and survival
    Whitworth, Pat
    Pellicane, James V., Jr.
    Baron, Paul
    Beitsch, Peter
    Lee, Laura
    Rotkis, Michael
    Mislowsky, Angela
    Dul, Carrie
    Nash, Charles
    Nguyen, Bichlien
    Murray, Mary
    Richards, Paul
    Gittleman, Mark
    Akbari, Stephanie
    Wang, Shiyu
    Yoder, Erin B.
    Menicucci, Andrea
    Blumencranz, Lisa
    Audeh, William
    CANCER RESEARCH, 2021, 81 (04)
  • [42] Identification of racial disparities across MammaPrint and BluePrint subtypes in HR+HER2-breast cancer
    Reid, S.
    Whisenant, J. G.
    Wei, J.
    Ramaswamy, H.
    Stivers, N.
    Menicucci, A.
    Audeh, W.
    Pal, T.
    ANNALS OF ONCOLOGY, 2024, 35 : S344 - S344
  • [43] Prognostic and Predictive Markers for Treatment Decisions in Early Breast Cancer
    Stickeler, Elmar
    BREAST CARE, 2011, 6 (03) : 193 - 198
  • [44] The Psychological Impact of Surgery Treatment Decisions for Breast Cancer: An Italian Study of Patients and Their Partners
    De Giorgi, Melissa
    Serpentini, Samantha
    Vidotto, Giulio
    Spoto, Andrea
    Capovilla, Eleonora
    PSYCHO-ONCOLOGY, 2014, 23 : 310 - 311
  • [45] Molecular subtyping using MammaPrint and BluePrint as an outcome predictor in US breast cancer (BC) patients.
    Yao, Katharine
    Turk, Mary
    Kaul, Karen
    Weaver, JoEllen
    De Snoo, Femke
    Stork-Sloots, Lisette
    Cristofanilli, Massimo
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (27)
  • [46] The impact of recurrence score versus sentinel lymph node biopsy on treatment decisions in early breast cancer
    Fowler, Rachel L.
    Lew, Kaitlyn P.
    Dizon, Don S.
    Ciambella, Chelsey C.
    Wakeley, Michelle
    Taneja, Charu
    Wiggins, Doreen L.
    Lopresti, Mary L.
    Constantinou, Maria
    Strenger, Rochelle
    Wang, Yihong
    Fenton, Mary A.
    Graves, Theresa
    CANCER RESEARCH, 2020, 80 (04)
  • [47] MammaPrint 8-year followup results in patients with early breast cancer from a single-center Italian cohort study
    Fiorino, E.
    Giudici, F.
    Aguggini, S.
    Strina, C.
    Milani, M.
    Ziglioli, N.
    Dester, M.
    Barbieri, G.
    Alberio, M.
    Azzini, C.
    Ferrero, G.
    Ungari, M.
    Dreezen, C.
    Pronin, D.
    Generali, D.
    BREAST, 2023, 68 : S76 - S77
  • [48] Genomic Grade Index (GGI): Feasibility in Routine Practice and Impact on Treatment Decisions in Early Breast Cancer
    Metzger-Filho, Otto
    Catteau, Aurelie
    Michiels, Stefan
    Buyse, Marc
    Ignatiadis, Michail
    Saini, Kamal S.
    de Azambuja, Evandro
    Fasolo, Virginie
    Naji, Sihem
    Canon, Jean Luc
    Delree, Paul
    Coibion, Michel
    Cusumano, Pino
    Jossa, Veronique
    Kains, Jean Pierre
    Larsimont, Denis
    Richard, Vincent
    Faverly, Daniel
    Cornez, Nathalie
    Vuylsteke, Peter
    Vanderschueren, Brigitte
    Peyro-Saint-Paul, Helene
    Piccart, Martine
    Sotiriou, Christos
    PLOS ONE, 2013, 8 (08):
  • [49] The cost impact of unselective vs selective MammaPrint testing in early-stage breast cancer in Southern Africa
    Myburgh, Ettienne J.
    de Jager, Josephus J.
    Murray, Elizabeth
    Grant, Kathleen A.
    Kotze, Maritha J.
    de Klerk, Hermanus
    BREAST, 2021, 59 : 87 - 93
  • [50] Different MammaPrint and BluePrint molecular profiles and clinical-pathological features of early stage breast cancer in Chinese patients in the United States and Hong Kong
    Kwong, Ava
    Untch, Sarah
    Kling, Heather M.
    Finn, Christine
    Audeh, William
    Shin, Vivian
    Ishtihar, Sherene
    Chen, Margaret
    CANCER RESEARCH, 2020, 80 (04)